Panacea Biotec’s arm makes further investment in Panacea Biotec Inc

28 Dec 2024 Evaluate

Panacea Biotec’s material subsidiary -- Panacea Biotec Pharma (PBPL) has made further investment of $9,25,000 (Rs 7.92 crore) in Panacea Biotec Inc., a wholly-owned subsidiary (WOS) company, as subscription for 9,25,00,000 shares of common stock of Panacea Biotec Inc. at a price of $0.01 per share.

The WOS has been set-up with an objective of establishing presence in the world’s largest healthcare market in US by pursuing comprehensive range of activities, including the buying, selling, marketing, importing, exporting, distributing, and dealing in services and products related to health and wellness, such as nutrition, dietary supplements, OTC drugs, medical devices, prescription drugs, and vaccines. The investment made by PBPL in WOS is to facilitate the capex and working capital requirements of PB Inc. and is in furtherance of its business. The business of the WOS is in line with the business activities of the company and PBPL. 

Panacea Biotec is a leading research based Biotechnology Company with established research, manufacturing and marketing capabilities. 


Panacea Biotec Share Price

325.10 -6.85 (-2.06%)
02-Mar-2026 11:35 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1738.35
Dr. Reddys Lab 1281.40
Cipla 1340.50
Zydus Lifesciences 903.15
Lupin 2284.40
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×